Investor resources
Clinical-stage risk
BioVie is pre-revenue from product sales and requires capital to fund operations and research. Drug development is uncertain, expensive and subject to clinical, regulatory, financing, competitive and operational risks. Review the latest SEC filings before making any investment decision.
Not investment advice
This website provides company information and does not offer securities, recommend a transaction or provide investment advice. Market prices can be volatile, and investors can lose some or all of their investment.
Evidence and compliance note
Development-stage information can change. Investigational candidates are not approved, and safety and efficacy have not been established. Review source documents and current regulatory disclosures.
